Financière de Tubize SA (LON:0D53)

Market Cap	9.03B +13.4%
Revenue (ttm)	n/a
Net Income	84.74M +6.1%
EPS	1.85 +6.1%
Shares Out	n/a
PE Ratio	110.45
Forward PE	n/a
Dividend	0.66 (0.32%)
Ex-Dividend Date	May 7, 2026

Volume	27
Open	247.00
Previous Close	247.80
Day's Range	244.20 - 247.00
52-Week Range	169.70 - 250.50
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2027

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1928
• Employees: 3
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0D53

Financial Performance

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error